Lab Demand Is Up 44% and Landlords Are Losing Anyway
Vacancy near 32% has cut lease terms by 30% — the recovery is arriving on tenants' paper.
CRE 360 Signal·Jul 20, 2026
Topic archive
Life Sciences
CRE 360 Signal editorial tag
7 published items
Newsletters
Signals
Lab Space Just Posted Its Biggest Absorption Turn in a Decade
Vacancy is still ugly, but availability is falling and demand is surging.
CRE 360 Signal Editorial Desk·Jul 15, 2026
A Radiopharma Developer Takes a Full Building — and Onshores Manufacturing
AdvanCell's 128K SF Andover lease is a bet on U.S. drug production, not just lab space.
CRE 360 Signal Editorial Desk·Jul 6, 2026
Lab Space Just Hit Bottom — But Only the Best Buildings Get Saved
Availability is contracting for the first time in years, and the recovery is splitting by quality and metro.
CRE 360 Signal Editorial Desk·Jun 28, 2026
The Lab-Space Boom Just Failed Its First Leasing Test
Roughly three-quarters of 2025's new life sciences supply is still sitting empty.
CRE 360 Signal Editorial Desk·Jun 4, 2026
Zero Public Biotech Leases. That's the Story.
Alexandria's Q1 print broke the "life sciences bottoming" thesis in a single line on the earnings call.
CRE 360 Signal Editorial Desk·May 3, 2026